Delivery Order SPE2DB20D1050-SPE2DB25FH49L

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,718.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Loryna 3 mg-0.02 mg tablets, a type of oral contraceptive medication, with a completion date of September 23, 2024. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
The federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,875.38 firm fixed-price delivery order is for the drug product LORYNA 3 MG-0.02 MG TABLET 28S, with a completion date of November 10, 2022. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,775.06 Firm Fixed Price Delivery Order contract is for the supply of 4562888476 LORYNA 3 MG-0.02 MG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of November 24, 2023 and was awarded on November 22, 2023. This award is associated with a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,640.67, is a delivery order for Loryna 3 mg-0.02 mg tablets. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,133.10, is for the delivery of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. This is a firm fixed-price delivery order contract with a completion date of November 16, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of the pharmaceutical product "LORYNA 3 MG-0.02 MG TABLET 28S" with a ceiling value of $1,450.40. The contract is a firm fixed price delivery order with a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,032.64 firm fixed-price delivery order is for the supply of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S, with an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The $1,597.98 firm fixed price delivery order is for the supply of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. This contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FL7C6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $4,077.49, is a Firm Fixed Price Delivery Order for the supply of pharmaceutical products, including the drug LORYNA 3 MG-0.02 MG TABLET 28S. The contract has an ultimate completion date of November 30, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor. The $1,373.88 firm-fixed-price delivery order is for the supply of LORYNA 3 MG-0.02 MG TABLET 28S, a contraceptive medication. The contract has an ultimate completion date of September 12, 2024 and was awarded on September 11, 2024. This award is likely part of a larger Indefinite Delivery Contract...
  • SPE2DB20D1050
    Indefinite Delivery Contract
  • SPE2DB20D1050-SPE2DB25FH49L
    Delivery Order

This federal contract award, valued at $5,509.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LORYNA 3 MG-0.02 MG TABLET 28S, a pharmaceutical product.

The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 9:47 AM